CDRE vs ENVX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CDRE exhibits a strong deterministic health profile with a Piotroski F-Score of 7/9 and excellent liquidity (Current Ratio 3.50), yet it faces severe valuation and growth headwinds. The stock is trading at a significant premium to its Graham Number ($13.15) and Intrinsic Value ($7.14), while simultaneously experiencing negative YoY revenue (-5.00%) and earnings growth (-13.30%). This fundamental deterioration is compounded by aggressive insider selling totaling $61.87M by the CEO, CFO, and President. Despite a 'strong_buy' analyst consensus, the technical trend is 0/100 and the price is hovering near its 52-week low, suggesting a disconnect between analyst targets and market reality.
ENVX shows neutral fundamentals based on deterministic rules. Financial strength is weak (F-Score 1/9). Mixed signals with both opportunities and risks present.
Compare Another Pair
Related Comparisons
CDRE vs ENVX: Head-to-Head Comparison
This page compares Cadre Holdings, Inc. (CDRE) and Enovix Corporation (ENVX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.